申请人:Allergan, Inc.
公开号:US05169963A1
公开(公告)日:1992-12-08
Compounds of the formula ##STR1## in which R.sub.1 independently is H or alkyl of 1 to 29 carbons, CO-R.sub.2, CO-O-R.sub.2, CO-NH-R.sub.2, or PO(OR.sub.2).sub.2 or PO(OR.sub.2)R.sub.2, where R.sub.2 independently is H, alkyl of 1 to 20 carbons, phenyl, or lower alkyl substituted phenyl or halogen substituted phenyl; A is (CH.sub.2).sub.n where n ranges between 0 to 30, or A is a a divalent branch chained alkyl radical, or cycloalkyl radical, having a total of 3 to 30 carbons; R.sub.3 independently is an alkyl group having 4 to 20 carbons, and X is O or NH, have anti-inflammatory activity.
具有以下结构式的化合物 ##STR1## 中,其中 R.sub.1 独立地为 H 或含有 1 到 29 个碳原子的烷基,CO-R.sub.2,CO-O-R.sub.2,CO-NH-R.sub.2,或 PO(OR.sub.2).sub.2 或 PO(OR.sub.2)R.sub.2,其中 R.sub.2 独立地为 H,含有 1 到 20 个碳原子的烷基,苯基,或取代苯基的较低烷基或卤代苯基;A 为 (CH.sub.2).sub.n,其中 n 范围在 0 到 30 之间,或 A 为二价支链烷基基团,或环烷基基团,总共含有 3 到 30 个碳原子;R.sub.3 独立地为含有 4 到 20 个碳原子的烷基基团,X 为 O 或 NH,具有抗炎活性。